Pg. Lawlor et al., Occurrence, causes, and outcome of delirium in patients with advanced cancer - A prospective study, ARCH IN MED, 160(6), 2000, pp. 786-794
Citations number
48
Categorie Soggetti
General & Internal Medicine","Medical Research General Topics
Context: Delirium impedes communication and contributes to symptom distress
in patients with advanced cancer. There are few prospective data on the re
versal of delirium in this population.
Objectives: To evaluate the occurrence, precipitating factors, and reversib
ility of delirium in patients with advanced cancer.
Design: Prospective serial assessment in a consecutive cohort of 113 patien
ts with advanced cancer. Precipitating factors were examined using standard
ized criteria; 104 patients met eligibility criteria.
Setting: Acute palliative care unit in a university-affiliated teaching hos
pital.
Main Outcome Measures: Delirium occurrence and reversal rates, duration, an
d patient survival. Strengths of association of various precipitating facto
rs with reversal were expressed as hazard ratios (HRs) in univariate and mu
ltivariate analyses.
Results: On admission, delirium was diagnosed in 44 patients (42%), and of
the remaining 60, delirium developed in 27 (45%). Reversal of delirium occu
rred in 46 (49%) of 94 episodes in 71 patients. Terminal delirium occurred
in 46 (88%) of the 52 deaths. In univariate analysis, psychoactive medicati
ons, predominantly opioids (HR, 8.85; 95% confidence interval [CI], 2.13-36
.74), and dehydration (HR, 2.35; 95% CI, 1.20-4.62) were associated with re
versibility. Hypoxic encephalopathy (HR, 0.39; 95% CI, 0.19-0.80) and metab
olic factors (HR, 0.44; 95% CI, 0.21-0.91) were associated with nonreversib
ility. In mulitivariate analysis, psychoactive medications (HR, 6.65; 95%;
CI, 1.49-29.62), hypoxic encephalopathy (HR, 0.32; 95% CI, 0.15-0.70), and
nonrespiratory infection (HR, 0.23; 95% CI, 0.08-0.64) had independent asso
ciations. Patients with delirium had poorer survival rates than controls (P
< .001).
Conclusions: Delirium is a frequent, multifactorial complication in advance
d cancer. Despite its terminal presentation in most patients, delirium is r
eversible in approximately 50% of episodes. Delirium precipitated by opioid
s and other psychoactive medications and dehydration is frequently reversib
le with change of opioid or dose reduction, discontinuation of unnecessary
psychoactive medication, or hydration, respectively.